Chemoinformaics analysis of 1,1,6-Trimethyltetralin
| Molecular Weight | 174.287 | nRot | 0 |
| Heavy Atom Molecular Weight | 156.143 | nRig | 11 |
| Exact Molecular Weight | 174.141 | nRing | 2 |
| Solubility: LogS | -5.677 | nHRing | 0 |
| Solubility: LogP | 5.051 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 33.7123 |
| nHD | 0 | BPOL | 18.0577 |
| QED | 0.563 |
| Synth | 2.102 |
| Natural Product Likeliness | 0.706 |
| NR-PPAR-gamma | 0.109 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.769 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.595 |
| MDCK | 0.0000136 |
| BBB | 0.433 |
| PPB | 0.960365 |
| VDSS | 3.187 |
| FU | 0.0378923 |
| CYP1A2-inh | 0.775 |
| CYP1A2-sub | 0.933 |
| CYP2c19-inh | 0.693 |
| CYP2c19-sub | 0.861 |
| CYP2c9-inh | 0.315 |
| CYP2c9-sub | 0.785 |
| CYP2d6-inh | 0.668 |
| CYP2d6-sub | 0.916 |
| CYP3a4-inh | 0.204 |
| CYP3a4-sub | 0.398 |
| CL | 4.889 |
| T12 | 0.138 |
| hERG | 0.059 |
| Ames | 0.021 |
| ROA | 0.127 |
| SkinSen | 0.529 |
| Carcinogencity | 0.066 |
| EI | 0.987 |
| Respiratory | 0.473 |
| NR-Aromatase | 0.045 |
| Antiviral | No |
| Prediction | 0.615816 |